Roche Holding | Netto Inntekt



Net Income Endring Dato
AbbVie USD 1.29B 1.31B 2025-03
Alcon AG USD 284M 21M 2024-12
Almirall EUR 7.99M 590K 2024-06
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Fresenius EUR 229M 11M 2025-03
Fresenius Medical Care EUR 151M 84.1M 2025-03
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Lonza CHF 329M 85M 2024-06
Merck EUR 667M 142M 2024-12
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Orion EUR 61.2M 12.2M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Philips EUR 75M 410M 2025-03
Recordati EUR 113.03M 11.25M 2024-09
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06



Roche Holding Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.